XNAS: ALLO
Allogene Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases. Its pipeline includes "off-the-shelf"...
Read More
2.00
-0.10
(-4.76%)
7.8M
XNAS Volume
XNAS 10 Jul, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Allogene Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..